Ophthalmogenetics and Gene Therapy

Ophthalmic hereditary qualities are worried about the hereditary commitment to ophthalmic illness, including assurance of examples and dangers of legacy, and in addition finding, visualization, and advancement of medications for hereditary variations from the norm. The advances in gene therapy maintain extensive promise for the cure of ophthalmic conditions. Gene therapy is additionally in a position to deal with primary open-angle glaucoma (POAG) in animal models, and research show it is economically viable. Genes may additionally be delivered into cells in vitro or in vivo making use of viral or non-viral vectors. Recent technical advances have led to the demonstration of the molecular basis of a range of ocular diseases.

  • Genetics of Myopia Development
  • Gene Therapy
  • Usher syndrome
  • Familial exudative vitreal retinopathy
  • Retinoblastoma
  • Leber hereditary optic neuropathy (LHON)
  • Optic atrophy
  • Genetics of Myopia Development

Related Conference of Ophthalmogenetics and Gene Therapy

October 19-20, 2020

19th Asia Pacific Ophthalmologists Annual Meeting

Singapore City, Singapore
October 22-23, 2020

World Congress on Ophthalmology and Optometry

Tokyo, Japan
October 28-29, 2020

30th World Congress on Ophthalmology and Optometry

Amsterdam, Netherlands
November 23-24, 2020

3rd World Congress on Eye and Vision

Istanbul, Turkey
November 23-24, 2020

3rd World Eye and Vision Congress

Istanbul, Turkey
November 23-24, 2020

34th European Ophthalmology Congress

Rome, Italy
December 07-08, 2020

4th Annual Conference on Orthopedics, Rheumatology and Osteoporosis

Prague, Czech Republic
March 17-18, 2021

European Conference on Ophthalmology & Eye care

Budapest, Aland Islands
August 23-24, 2021

21st Global Ophthalmologists Annual meeting

London, UK
August 23-24, 2021

2nd World Congress on Ophthalmology & Optometry

London, UK

Ophthalmogenetics and Gene Therapy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in